Isodiol Partners with Europes Top MMA Company to Market ISO-Sport CBD Products | CashCropToday
0 Shares 245 Views

Isodiol Partners with Europes Top MMA Company to Market ISO-Sport CBD Products

February 13, 2018
245 Views

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) has recently announced a partnership with European Mixed Martial Arts (MMA) company Cage Warriors to promote and distribute a line of CBD products for training and recovery.

Cage Warriors will be assisting Isodiol promote ISO-Sport™ branded products across the European continent. The product line will include CBD based beverages, topicals, oral sprays, drops, protein powder, and other supplements products.

MMA fighters are training constantly for upcoming fights, and their sometime lengthy careers takes a toll on their bodies. CBD products have been known to contain anti-inflammatory properties which is why this partnership makes sense. The companies plan
to target the products towards the personal wellness industry.

President of ISO-Sport™ Troy Nihart said, “Cage Warriors is the home to many of the best MMA fighters around the world, making this partnership an easy decision for us,” “ISO-Sport™ will begin to develop new innovative products specifically for MMA fighters to help throughout their daily lives, training and recovery process.  We are excited about the tremendous amount of exposure this partnership will provide to the ISO-Sport™ brand.”

Link to the press release

 

 

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
187 views
Global
187 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
185 views
Manufacturing
185 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: